Clinical Trial Update: Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors

View source ↗

Summary

A clinical trial is evaluating PET imaging targeting CLDN18.2 for detecting malignant tumors, with recruitment ongoing in gastric cancer, pancreatic cancer, cho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Esophageal Cancer
• Gastric Cancer
• Pancreatic Cancer

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Gastric Cancer, Pancreatic Cancer | Status: RECRUITING